Belimumab Benlysta® |
Formulary
|
Concentrate for solution for infusion 120mg, 400mg RAG for NICE TA806: TA806 Belimumab for treating lupus nephritis (terminated appraisal) |
MHRA: Belimumab (Benlysta▼): increased risk of serious psychiatric events seen in clinical trials NICE TA752:Belimumab for treating active autoantibody-positive systemic lupus erythematosus NICE TA806: Belimumab for treating lupus nephritis (terminated appraisal) |
|